-
M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down
Monday, December 14, 2015 - 12:59pm | 512Read More...Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty. The latest...
-
More Wild Short Interest Swings In Biotech Stocks
Sunday, December 13, 2015 - 5:52pm | 924Read More...Short interest moves in leading biotech stocks were mixed in the most recent period. However, Illumina, Inc. (NASDAQ: ILMN) and Baxalta Inc (NYSE: BXLT) saw sharp increases in their short interest in late November. Short sellers appeared to lose interest in Juno Lighting LLC (NASDAQ: JUNO) late in...
-
Dyax Corp, BioCryst Pharma Lead Tuesday's After-Hours Movers
Tuesday, March 31, 2015 - 7:40pm | 450Read More...Dyax Corp. (NASDAQ: DYAX) jumped nearly 49 percent to $24.90 a share in late trading Tuesday after the company said a Phase Ib trial of its DX-2930 drug met safety goals and demonstrated statistically significant reductions in attack rates of hereditary angiodema, a rare disease. Tahoe...
